Arkolith/Insider Trading/ABCL/Form 4

Lecault Veronique

Chief Operating Officer, DirectorAbCellera Biologics Inc. (ABCL) · full profile →Form 4 · filed Mar 1, 2022
Net Buying
Open-Market Buys
$2.0M
Open-Market Sells
$0
Net Open-Market Flow
$2.0M
Transactions
1
1 non-derivative · 0 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Feb 28, 2022Buy(P)231K$8.66$2.0M1.6M

Transaction Codes

P
Open-market purchase

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001209191-22-014395) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML